Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

首页> 外文期刊>Bone marrow transplantation >Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

【24h】

Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

机译：同种异体HCT接受者在甲状腺炎毒素和钙调素抑制剂之间缺乏显着的药代动力学相互作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2020年第8期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients [J] . Bone marrow transplantation . 2020,第8期

机译：同种异体HCT接受者在甲状腺炎毒素和钙调素抑制剂之间缺乏显着的药代动力学相互作用
2. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients. [J] . Mori T, Aisa Y, Kato J Bone marrow transplantation . 2009,第6期

机译：伏立康唑和钙调神经磷酸酶抑制剂在同种异体造血干细胞移植受者中的药物相互作用。
3. Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole. [J] . Mori T, Aisa Y, Kato J International journal of hematology . 2009,第1期

机译：异体造血干细胞移植受者口服伊曲康唑和钙调神经磷酸酶抑制剂之间的药物相互作用：与伊曲康唑口服溶液的生物利用度相关。
4. UTILIZATION OF AN EMR-BIOREPOSITORY TO IDENTIFY THE GENETIC PREDICTORS OF CALCINEURIN-INHIBITOR TOXICITY IN HEART TRANSPLANT RECIPIENTS [C] . MATTHEW OETJENS, WILLIAM S. BUSH, KELLY A. BIRDWELL, Pacific Symposium on Biocomputing . 2014

机译：利用EMR-BioRepository以鉴定心脏移植受者钙素抑制剂毒性的遗传预测因子
5. Pharmacokinetics of intraarterial calcineurin inhibitor delivery to composite tissue: A study of regional and systemic advantages of intraarterial delivery of calcineurin inhibitors (cyclosporine and tacrolimus) to a vascularly isolated rabbit forelimb. [D] . Shirbacheh, Mansour V. 1999

机译：动脉钙调神经磷酸酶抑制剂向复合组织递送的药代动力学：钙调神经磷酸酶抑制剂（环孢素和他克莫司）向血管分离的兔前肢的动脉内递送的区域和全身优势的研究。
6. A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT) [O] . Johan Maertens, Michael Schmitt, Francisco M Marty, 2017

机译：同种异体造血细胞移植（HCT）的CMV血清反应阳性接受者中巨细胞病毒（CMV）感染性莱特莫韦预防试验的死亡率分析
7. 1730. Outcomes of Patients With Detectable Cytomegalovirus (CMV) DNA at Randomization in the Double-blind, Placebo-Controlled Phase 3 Trial of Letermovir (LET) Prophylaxis for CMV-Seropositive Allogeneic Hematopoietic-Cell Transplantation (HCT) Recipients [O] . Francisco M Marty, Per Ljungman, Roy F Chemaly, 2018

机译：1730. 1730.在双盲，安慰剂对照相3试验中随机化的患者的患者的结果（Letermovir（Let）预防CMV-血清阳性同种异体造血 - 细胞移植（HCT）接受者

Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients

著录项

相似文献

相关主题

期刊订阅